Vitrolife AB (publ)

Vitrolife AB (publ)

VTRLY - Insider Information

Get informed when a big investor buys or sells

+ Follow
Market Cap$1.36B
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Vitrolife AB (publ)Vitrolife AB (publ)-3.30.92%-60%0.40.2
$3.42

Current Fair Value

66.6% downside

Overvalued by 66.6% based on the discounted cash flow analysis.

Insider Trades

Loading insider trades…

Congress Trades

Loading congress trades…

Share Statistics

Market cap$1.36 Billion
Enterprise Value$2.23 Billion
Annual dividend$0.12
Dividend yield0.92%
Earnings per Share$-34.79
Beta1.71
Outstanding Shares134,086,364

Return

Return on Equity-60.38%ROE
Return on Assets-42.92%
Return on Invested Capital-43.45%

Valuation & Multiples

P/E Ratio-3.26P/E Ratio
PEG-13.84PEG
Price to Sales0.41Price to Sales
Price to Book Ratio0.17Price to Book Ratio
Enterprise Value to Revenue0.65
Enterprise Value to EBIT-0.47
Enterprise Value to Net Income-1
Total Debt to Enterprise0.78
Debt to Equity0.21Debt to Equity

Revenue Sources

No data

Institutional Sentiment (Put/Call)

No data available for the latest quarter.

Institutional Ownership

No data available for the latest quarter.

About Vitrolife AB

1,151 employees
CEO: Bronwyn Brophy O'Connor

Vitrolife AB (publ) engages in development, production, and marketing of products for assisted reproduction. It provides oocyte retrieval needles; sperm processing; in vitro fertilization media and oil; micromanipulation pipettes; labwar...